Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory L Willis

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Reviews in the Neurosciences|August 23, 2023
Fine-tuning the circadian system with light treatment for Parkinson's disease: an in-depth, critical reviewGregory L Willis, Stuart M Armstrong
Pharmacology, Biochemistry, and Behavior|December 8, 2004
Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptorGregory L Willis, Alan D Robertson
Behavioural Brain Research|November 29, 2017
The effect of intravitreal cholinergic drugs on motor controlGregory L Willis, Christopher B Freelance
Reviews in the Neurosciences|March 30, 2004
The implementation of acute versus chronic animal models for treatment discovery in Parkinson's diseaseGregory L Willis, Gerard A Kennedy
Physiology & Behavior|September 19, 2017
The effect of directed photic stimulation of the pineal on experimental Parkinson's diseaseGregory L Willis, Christopher B Freelance
Chronobiology International|July 7, 2007
Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series studyGregory L Willis, E John D Turner
Journal of Medical Case Reports|October 23, 2024
Circadian re-set repairs long-COVID in a prodromal Parkinson's parallel: a case seriesGregory L Willis, Takuyuki Endo, Saburo Sakoda
Reviews in the Neurosciences|April 14, 2012
A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson's diseaseGregory L Willis, Cleo Moore, Stuart M Armstrong
Reviews in the Neurosciences|October 24, 2012
Breaking away from dopamine deficiency: an essential new direction for Parkinson's diseaseGregory L Willis, Cleo Moore, Stuart M Armstrong
Frontiers in Neurology|February 20, 2019
Polychromatic Light Exposure as a Therapeutic in the Treatment and Management of Parkinson's Disease: A Controlled Exploratory TrialGregory L Willis, Jamilee Boda, Christopher B Freelance
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Reviews in the Neurosciences|August 23, 2023
Fine-tuning the circadian system with light treatment for Parkinson's disease: an in-depth, critical reviewGregory L Willis, Stuart M Armstrong
Pharmacology, Biochemistry, and Behavior|December 8, 2004
Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptorGregory L Willis, Alan D Robertson
Behavioural Brain Research|November 29, 2017
The effect of intravitreal cholinergic drugs on motor controlGregory L Willis, Christopher B Freelance
Reviews in the Neurosciences|March 30, 2004
The implementation of acute versus chronic animal models for treatment discovery in Parkinson's diseaseGregory L Willis, Gerard A Kennedy
Physiology & Behavior|September 19, 2017
The effect of directed photic stimulation of the pineal on experimental Parkinson's diseaseGregory L Willis, Christopher B Freelance
Chronobiology International|July 7, 2007
Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series studyGregory L Willis, E John D Turner
Journal of Medical Case Reports|October 23, 2024
Circadian re-set repairs long-COVID in a prodromal Parkinson's parallel: a case seriesGregory L Willis, Takuyuki Endo, Saburo Sakoda
Reviews in the Neurosciences|April 14, 2012
A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson's diseaseGregory L Willis, Cleo Moore, Stuart M Armstrong
Reviews in the Neurosciences|October 24, 2012
Breaking away from dopamine deficiency: an essential new direction for Parkinson's diseaseGregory L Willis, Cleo Moore, Stuart M Armstrong
Frontiers in Neurology|February 20, 2019
Polychromatic Light Exposure as a Therapeutic in the Treatment and Management of Parkinson's Disease: A Controlled Exploratory TrialGregory L Willis, Jamilee Boda, Christopher B Freelance
Pageof 3